Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients.

New AI model using XGBoost accurately diagnoses prostate cancer in low-PSA patients, reducing biopsy need and enhancing ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.